Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

The Impact of Cytomegalovirus Infection on Respiratory Disease Progression in Cystic Fibrosis

FY 2021-22

Summary
Cystic fibrosis (CF) is the most prevalent fatal genetic disease affecting Caucasian populations. Owing to reduced chloride ion transport across epithelial surfaces, thick mucus secretions accumulate across the systemic epithelium. Impaired mucocilliary clearance within the airways and resultant chronic bacterial infection are the primary drivers of CF-related morbidity and mortality. However, bacterial infection status poorly correlates with long term outcomes, highlighting the need to identify other variables influencing CF disease progression. In recent years, cytomegalovirus (CMV, a ubiquitous DNA virus) has been identified as a potential contributor to disproportionate progression of many inflammatory diseases. In 2020, it was shown that people with CF (pwCF) who were CMV seropositive progressed to end-stage lung disease significantly faster than those that were seronegative (by 8 years). Furthermore, CMV DNA has been found in sputum of those with advanced disease. The aim of this work is to establish the prevalence, risk factors, and dynamics of CMV in sputum and serum of pwCF, collected from multiple sites across Canada over the course of five years. Further, this study will aim to investigate the effect of CMV infection in bronchial epithelial cells in vitro, using CF- and non-CF cell lines. We suspect that patients with CMV seropositivity and those experiencing incident CMV infection (seroconversion) will demonstrate worse baseline disease status and disease progression over time. The findings of this study will provide unique insight into a previously unexplored mechanism of disease pathogenesis, and if confirmed, could open the door to clinical studies using established CMV-therapeutics and evolving CMV vaccines to mitigate its effect.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466677
Name
Svishchuk Julianna
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Impact of Cytomegalovirus Infection on Respiratory Disease Progression in Cystic Fibrosis
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Infection; Cystic Fibrosis; Cytomegalovirus; Exacerbation; Herpesvirus; Inflammation; Lung Function; Seroconversion
Abstract
Cystic fibrosis (CF) is the most prevalent fatal genetic disease affecting Caucasian populations. Owing to reduced chloride ion transport across epithelial surfaces, thick mucus secretions accumulate across the systemic epithelium. Impaired mucocilliary clearance within the airways and resultant chronic bacterial infection are the primary drivers of CF-related morbidity and mortality. However, bacterial infection status poorly correlates with long term outcomes, highlighting the need to identify other variables influencing CF disease progression. In recent years, cytomegalovirus (CMV, a ubiquitous DNA virus) has been identified as a potential contributor to disproportionate progression of many inflammatory diseases. In 2020, it was shown that people with CF (pwCF) who were CMV seropositive progressed to end-stage lung disease significantly faster than those that were seronegative (by 8 years). Furthermore, CMV DNA has been found in sputum of those with advanced disease. The aim of this work is to establish the prevalence, risk factors, and dynamics of CMV in sputum and serum of pwCF, collected from multiple sites across Canada over the course of five years. Further, this study will aim to investigate the effect of CMV infection in bronchial epithelial cells in vitro, using CF- and non-CF cell lines. We suspect that patients with CMV seropositivity and those experiencing incident CMV infection (seroconversion) will demonstrate worse baseline disease status and disease progression over time. The findings of this study will provide unique insight into a previously unexplored mechanism of disease pathogenesis, and if confirmed, could open the door to clinical studies using established CMV-therapeutics and evolving CMV vaccines to mitigate its effect.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Svishchuk, Julianna
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~